Comment
doi: 10.1056/NEJMp038108.
From presumed benefit to potential harm--hormone therapy and heart disease
Affiliations
- PMID: 12904515
- DOI: 10.1056/NEJMp038108
Item in Clipboard
Comment
From presumed benefit to potential harm--hormone therapy and heart disease
N Engl J Med.
.
No abstract available
Comment in
-
Hormone therapy and cardiovascular disease.N Engl J Med. 2003 Nov 20;349(21):2075-6. N Engl J Med. 2003. PMID: 14631933 No abstract available.
Comment on
-
Estrogen plus progestin and the risk of coronary heart disease.N Engl J Med. 2003 Aug 7;349(6):523-34. doi: 10.1056/NEJMoa030808. N Engl J Med. 2003. PMID: 12904517 Clinical Trial.
-
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.N Engl J Med. 2003 Aug 7;349(6):535-45. doi: 10.1056/NEJMoa030830. N Engl J Med. 2003. PMID: 12904518 Clinical Trial.
Similar articles
-
Hormone-replacement therapy and cardiovascular diseases.N Engl J Med. 2003 Aug 7;349(6):521-2. doi: 10.1056/NEJMp038110. N Engl J Med. 2003. PMID: 12904516 No abstract available.
-
[Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].Wiad Lek. 2006;59(5-6):377-82. Wiad Lek. 2006. PMID: 17017486 Review. Polish.
-
Postmenopausal hormone replacement therapy: does the progestin make a difference?J S C Med Assoc. 2002 Feb;98(1):12-9. J S C Med Assoc. 2002. PMID: 11859600 Review. No abstract available.
-
[Postmenopausal hormone replacement therapy and cardiovascular disease].Tidsskr Nor Laegeforen. 2002 Jun 20;122(16):1564-5. Tidsskr Nor Laegeforen. 2002. PMID: 12119783 Review. Norwegian. No abstract available.
-
Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?Ann Med. 2004;36(6):402-13. doi: 10.1080/07853890410035430. Ann Med. 2004. PMID: 15513292 Review.
Cited by
-
Effects of chronic hyperinsulinemia in insulin-resistant patients.Curr Diab Rep. 2008 Jun;8(3):233-8. doi: 10.1007/s11892-008-0040-z. Curr Diab Rep. 2008. PMID: 18625122 Review.
-
Point-counterpoint. The triumph of the null hypothesis: epidemiology in an age of change.Int J Epidemiol. 2009 Apr;38(2):393-402. doi: 10.1093/ije/dyn268. Epub 2008 Dec 17. Int J Epidemiol. 2009. PMID: 19091776 Free PMC article.
-
Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women.J Endocrinol Invest. 2005 Jul-Aug;28(7):623-31. doi: 10.1007/BF03347261. J Endocrinol Invest. 2005. PMID: 16218045 Clinical Trial.
-
Long-term safety of bisphosphonate therapy for osteoporosis: a review of the evidence.Drugs Aging. 2006;23(4):289-98. doi: 10.2165/00002512-200623040-00002. Drugs Aging. 2006. PMID: 16732688 Review.
-
Wat kunnen we leren van de mislukking van de hormoonsuppletietherapie?Neth Heart J. 2003 Oct;11(10):433. Neth Heart J. 2003. PMID: 25696155 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
